Brief: Shanghai Haohai Biological Technology Co Says FY Profit Attributable RMB414.5 Million
15/03/2019 01:11
March 15 (Reuters) - Shanghai Haohai Biological Technology
Co Ltd 6826.HK :
* FY REVENUE RMB1.55 BILLION VERSUS RMB1.34 BILLION
* FY PROFIT ATTRIBUTABLE RMB414.5 MILLION VERSUS RMB372.4
MILLION
Source text for Eikon: ID:nHKS8ZzL8N
Further company coverage: 6826.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.